Team:LCG-UNAM-Mexico/Notebook/2008-August

From 2008.igem.org

(Difference between revisions)
Line 201: Line 201:
         </tr>
         </tr>
         <tr>
         <tr>
-
<td class="bodyText"><p>August 11th(summary)- -- -- -- -- -- -- --  - ------ -----. --- ------ --- ---- -- --- ----- -- -- -- ------ ---- ---- - -- - ---- - ----- ---- ---, - ----- --- ----- ---- ---- ---- -- --- --- --- --- -- ---- ---------- - ------ ---- --- ---- ----- --- --- ----- ---- ----- ------ ---- -- -- --- ------- - ----- --- ---- --- --- -- - ------ -- ---- ---  ---  --- -- -- ----- ---, --- - --- -- -- -- -- -- -- --   - ------ -----.
+
<td class="bodyText"><p><strong>GROUP MEETING </strong><br />
-
--- ------ --- ---- -- --- ----- -- -- -- ------ ---- ---- - -- - ---- - ----- ---- ---, - ----- --- ----- ---- ---- ---- -- --- --- --- --- -- ---- ---------- - ------ ---- --- ---- ----- --- --- ----- ---- ----- ------ ---- -- -- --- ------- - ----- --- ----. </p>
+
  Experimental work<br />
 +
  <strong><br />
 +
  Objectives: </strong><br />
 +
  - Build the bioparts. <br />
 +
  - Transform the bacteria with the construction that we have. <br />
 +
  - Design the experiments to test our construction. <br />
 +
  - Build the system. <br />
 +
  - Collaborate with the modeling group. <br />
 +
  <br />
 +
  <strong>To do: </strong><br />
 +
  - Extract DNA of the strain to get RcnA. <br />
 +
   - Get the bioparts catalog. <br />
 +
  - We need to have a large number of plasmids that we can use, amplifying the bioparts. <br />
 +
  - Transformation of the bacteria with bioparts. <br />
 +
  <br />
 +
  <strong>Currently:</strong><br />
 +
  - There are plasmids. <br />
 +
  - There are parts already amplified and in a plasmid. <br />
 +
  <br />
 +
  <strong>Problems: </strong><br />
 +
  - There was no DNA that we needed in the catalog. <br />
 +
  - The oligos were delayed 2 week and a half. <br />
 +
  - Issues to extract the plasmid from the colonies. <br />
 +
  - Make a PCR ligation with the three parts and amplify with the ends (it did not work). <br />
 +
  - With the enzyme used: Increased frequency of spontaneous mutation of all the enzymes that exist. <br />
 +
  An error every thousand base pairs. <br />
 +
  - There is a problem with tetracycline. You get false positives. <br />
 +
  <strong><br />
 +
  Can be done: </strong><br />
 +
  - A part with RcnA and can be linked to the plasmid. <br />
 +
  - In the others we have to link and restrict, and re-link and restrict once more and re-connect the last time in the final plasmid. <br />
 +
  HindIII can be used with the big biopart to verify the sequence. <br />
 +
  <strong><br />
 +
  Electrodes: </strong><br />
 +
   - Are they specific for Nickel?</p>
 +
<p>&nbsp;</p>
         </td>
         </td>
       </tr>  
       </tr>  

Revision as of 19:44, 29 September 2008

LCG-UNAM-MexicoTeam

Header image
iGEM 2008 TEAM
line decor
  
line decor

 
 
 
 
 
 
August

2008-08-04

Hill's cooperativity
5th Reaction
Reminder:

A + B <--> AB           
Ka=Keq=[AB]/[A][B]=1/Kd     
θ=[AB]/([AB]+[A])=[B]/([B]+Kd)

MWC Model (Cooperativity)           
A + nB <--> ABn       
Ka=Keq=[ABn]/[A][B]n=1/Kd  
θ=[B]n/([B]n+Kd)       
log(θ/(1- θ))=nlog(B)-log(kd)                        …Hill's equation

 

Suppression mediated by cI:
ρ + nCI <--> ρ:CIn     (k+, k-) 
Keq=Ka=[ρ:CIn]/[ρ][CI]n      
Si ρ0=[ρ]+[ρ:CIn]      
… ρ0=[ρ]+Keq[ρ][CI]n
=> ρ= (ρ0/Keq)/((1/keq)+[CI]n)

Flow= k+[ρ][CI]n = K+((ρ0/Keq)/((1/Keq)+[CI]n))[CI]n

Flow= k+([ρ0]/Keq) [CI]n / ((1/Keq)+[CI]n)

=> Vm= k+([ρ0]/Keq)   &   Kp=1/Keq=Kd

So:
Keq = exp( -ΔG / R T )          
k+ = (KB/h) T exp( -ΔG / R T ) = (KB/h) T Keq

Keq=

2.89517E+17

 

KB=

1.38E-23

J/K

k+=

1.79764E+30

/s

h=

6.63E-34

J s

R=

1.9872

cal/(K mol)

ΔG=

-23810

cal/mol

T=

298

K

 

2008-08-05

Hill's Cooperativity

5th Reaction, conflict ...

If we consider that:

Keq = exp (-ΔG / R T)

k + = (KB / h) T exp (-ΔG / R T) = (KB / h) T Keq

and given that the flow is (k + / Keq) [ρ0] [CI] n / ((1/Keq) + [CI] n), the value of the maximum speed of the flow loses its meaning.

The speed limit is being determined by (k + / Keq) [ρ0], but k + / Keq = (KB / h) * T, and we know that [ρ0] is arbitrary, i.e., Vmax is no longer based on the reaction as such, which does not make sense.

For example: Take the same reaction that we are considering, the maximum speed of the flow of the reaction would be the same with the promoter that has the operators of CI, that if you used one with a random sequence, so, whether we repeated the experiment, with the same temperature and the same concentration of DNA and an equal number of copies of the sequence, the maximum speed reached by the flow would be the same for the real promoter as for for any sequence, without taking any consideration with their affinity for their substrates... That does not makes sense!

The proposed explanation is that the equation used to determine k + does not fit our model, we should explore other possibilities.

 

2008-08-07

Hill's Cooperativity:
5th Reaction, resolving the conflict...

The error in the previous approach is that we were considering ΔG to be the same for both equations (for Keq & k+).

The explanation of why these two values are different is very clear when we look at the graph below. Recalling what the two constants represent:

We know that the balance depends solely on the difference between Gibbs free energy of the substrate and the product (ΔG 'th), The one with less energy will be favored in the balance, while the rate of reaction depends on the activation energy needed for the conversion (ΔG ‡). A reaction reaches equilibrium faster or slower depending on the rate of reaction (depending on how big is ΔG ‡), but the balance of it as such does not change.

Thus:
        Keq = exp (- ΔG 'º / R T)
        k + = (KB / h) T exp (- ΔG ‡ / RT) ≠ (KB / h) T Keq

 

2008-08-11

GROUP MEETING
Experimental work

Objectives:

- Build the bioparts.
- Transform the bacteria with the construction that we have.
- Design the experiments to test our construction.
- Build the system.
- Collaborate with the modeling group.

To do:
- Extract DNA of the strain to get RcnA.
- Get the bioparts catalog.
- We need to have a large number of plasmids that we can use, amplifying the bioparts.
- Transformation of the bacteria with bioparts.

Currently:
- There are plasmids.
- There are parts already amplified and in a plasmid.

Problems:
- There was no DNA that we needed in the catalog.
- The oligos were delayed 2 week and a half.
- Issues to extract the plasmid from the colonies.
- Make a PCR ligation with the three parts and amplify with the ends (it did not work).
- With the enzyme used: Increased frequency of spontaneous mutation of all the enzymes that exist.
An error every thousand base pairs.
- There is a problem with tetracycline. You get false positives.

Can be done:

- A part with RcnA and can be linked to the plasmid.
- In the others we have to link and restrict, and re-link and restrict once more and re-connect the last time in the final plasmid.
- HindIII can be used with the big biopart to verify the sequence.

Electrodes:

- Are they specific for Nickel?

 

2008-08-20

August 20th(summary)- -- -- -- -- -- -- -- - ------ -----. --- ------ --- ---- -- --- ----- -- -- -- ------ ---- ---- - -- - ---- - ----- ---- ---, - ----- --- ----- ---- ---- ---- -- --- --- --- --- -- ---- ---------- - ------ ---- --- ---- ----- --- --- ----- ---- ----- ------ ---- -- -- --- ------- - ----- --- ---- --- --- -- - ------ -- ---- --- --- --- -- -- ----- ---, --- - - --- -- -- -- -- -- -- -- - ------ -----. --- ------ --- ---- -- --- ----- -- -- -- ------ ---- ---- - -- - ---- - ----- ---- ---, - ----- --- ----- ---- ---- ---- -- --- --- --- --- -- ---- ---------- - ------ ---- --- ---- ----- --- --- ----- ---- ----- ------ ---- -- -- --- ------- - ----- --- ----.

2008-08-21

August 21st(summary)- -- -- -- -- -- -- -- - ------ -----. --- ------ --- ---- -- --- ----- -- -- -- ------ ---- ---- - -- - ---- - ----- ---- ---, - ----- --- ----- ---- ---- ---- -- --- --- --- --- -- ---- ---------- - ------ ---- --- ---- ----- --- --- ----- ---- ----- ------ ---- -- -- --- ------- - ----- --- ---- --- --- -- - ------ -- ---- --- --- --- -- -- ----- ---, --- - - --- -- -- -- -- -- -- -- - ------ -----. --- ------ --- ---- -- --- ----- -- -- -- ------ ---- ---- - -- - ---- - ----- ---- ---, - ----- --- ----- ---- ---- ---- -- --- --- --- --- -- ---- ---------- - ------ ---- --- ---- ----- --- --- ----- ---- ----- ------ ---- -- -- --- ------- - ----- --- ----.